EU nod for Shire’s longer-acting haemophilia A therapy
admin 15th January 2018 Uncategorised 0Shire’s Adynovi has been approved for use in Europe for on-demand and prophylactic use in patients 12 years and older with the rare bleeding disorder haemophilia A. More: EU nod for Shire’s longer-acting haemophilia A therapy Source: News
read more